In other recent news, Alzamend Neuro, Inc. has initiated a Phase II clinical study for its investigational drug AL001, designed to improve lithium delivery to the brain while minimizing blood levels.

In other recent news, Alzamend Neuro, Inc. has initiated a Phase II clinical study for its investigational drug AL001, designed to improve lithium delivery to the brain while minimizing blood levels.

1 Shmagel A, Foley R, Ibrahim H. Epidemiology of Chronic Low Back Pain in US Adults: Data From the 2009-2010 National Health and Nutrition Examination Survey. Arthritis Care Res (Hoboken). 2016 ...

BALTIMORE, May 21, 2025--ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced it has ...

ReGelTec Receives CE Mark for HYDRAFIL® System to Treat Chronic Low Back Pain Provided by Business Wire May 21, 2025, 11:05:00 AM.

The system is poised to join Stryker’s portfolio of pain management solutions, leveraging the company’s expertise in radiofrequency ablation technology and vertebral access.

Regular use of a common pain reliever weakens key immune system functions, potentially increasing infection risk and slowing recovery time for millions of users. Skip to content. News; ...

A breakthrough natural back pain relief program designed by wellness expert Emily Lark, the Back to Life Complete Healthy Back System uses a proven 3-phase movement method to improve posture, realign ...

Gaps in health system means one in five Aussie children are in pain. A fifth of Australian kids are suffering from painful issues like headaches unnecessarily for this reason.

Illustration by Dadu Shin. Chronic pain is remarkably common: Roughly 20% of adults in the US live with it. And people with chronic pain are more likely to have depression, anxiety, and substance ...

NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030.

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation on Wednesday, earlier than previously guided. NeuroOne Medical is ...